Research and Development

Dr Eliot Forster has been appointed chairman of MedCity Limited by the London mayor Boris Johnson. Dr Forster has 20 …

MedCity, the new entity seeking to capitalise on the so-called ‘golden triangle’ of medical and life sciences R&D organisations between …

Alkermes’ investigational schizophrenia drug has met its primary endpoint in a pivotal trial, leading the firm to seek regulatory approval …

The newly named Virgo Consumer Health & Wellbeing welcomes two new joiners – Matthew Coy and Reena Patel (both pictured), …

inVentiv Health has appointed Michael Griffith as its new executive vice president. In this capacity, Griffith will head inVentiv’s commercial …

PatientsLikeMe has set up a five-year agreement with Genentech, Roche’s biologics arm, to allow the firm access to patients’ real-world …

Like it or not, we are all becoming increasingly prone to a currently incurable and debilitating disease, that places an …

AbbVie will no longer seek to stop the European Medicines Agency from releasing data on its blockbuster arthritis treatment Humira. …

Sanofi UK and Ireland’s managing director Steve Oldfield has been elected as chair of the European Medicines Group (EMG).  Oldfield …

Newcastle-based biotech firm Glythera has appointed Dr Nigel Burns as non-executive director and Ian Evetts as commercial director.  Burns (pictured) …

Packaging firm PCI has welcomed Steve McCairns as its director of operations for its UK business.

  McCairns is a Lean …

Europe took a decisive step toward forcing pharma to open up its clinical trial data last night, after the EU …

Lundbeck has entered into a new partnership with the Lieber Institute for Brain Development in the hope of discovering new …

Merck’s US affiliate EMD Serono and Pfizer have entered into a research agreement with the Broad Institute to investigate autoimmune …